Burns James William — SEC Form 4 filings
SEC reporting owner CIK 1900772. 11 Form 4 filings on record with FilingPulse; latest filed 2026-06-23.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-01-09 to 2026-06-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 17 legs across 10 filings — 46,044 shares, $1,879,831 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 39.
- Largest priced transaction: sale of 13,411 shares @ $52.00 ($697,372) in AGIOS PHARMACEUTICALS, INC., filed 2024-11-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Legal Officer | 11 | — | 17 legs · 46,044 sh · $1,879,831 | 39 |
Form 4 filings — Burns James William
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-23 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 3,000 (derivative) @ $0 · Grant/award (A): 3,000 (derivative) @ $0 | EDGAR |
| 2026-04-06 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 8,500 @ $0 · Sale (S): 3,280 @ $34.71 · Option exercise (M): 8,500 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 4,000 @ $0 · Sale (S): 1,187 @ $28.96 · Option exercise (M): 5,666 @ $0 · Sale (S): 1,681 @ $28.96 · Option exercise (M): 4,000 @ $0 · Sale (S): 1,187 @ $28.96 · +8 more | EDGAR |
| 2026-01-02 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 6,000 @ $0 · Sale (S): 2,932 @ $27.09 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 6,000 @ $0 · Sale (S): 2,799 @ $33.54 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 3,833 @ $0 · Sale (S): 1,137 @ $35.54 · Option exercise (M): 4,000 @ $0 · Sale (S): 1,187 @ $35.54 · Option exercise (M): 5,667 @ $0 · Sale (S): 1,681 @ $35.54 · +6 more | EDGAR |
| 2024-11-12 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Sale (S): 13,411 @ $52 · Sale (S): 8,341 @ $52.56 | EDGAR |
| 2024-03-05 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 3,834 @ $0 · Sale (S): 1,293 @ $32.57 · Option exercise (M): 4,000 @ $0 · Sale (S): 1,349 @ $32.57 · Grant/award (A): 17,000 (derivative) @ $0 · Grant/award (A): 60,000 (derivative) @ $0 · +2 more | EDGAR |
| 2024-02-14 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 1,833 @ $0 · Sale (S): 545 @ $25.14 · Option exercise (M): 1,833 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 5,750 @ $0 · Sale (S): 1,708 @ $21.64 · Option exercise (M): 5,750 (derivative) @ $0 | EDGAR |
| 2024-01-09 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 3,250 @ $0 · Sale (S): 1,163 @ $22.99 · Option exercise (M): 3,250 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1900772 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →